COPD and Unexplained Hypoxaemia: a combination to be explored
Main Article Content
Abstract
Chronic obstructive pulmonary disease (COPD) is a slowly progressive disease characterized by inflammation that involves the airways, lung parenchyma, and pulmonary vasculature commonly associated with lung function decline and alveolar impairment of gas exchange. All these alterations can lead to hypoxaemia. In COPD hypoxaemia presenting refractory to very high concentration of inspired O2 with a drop of SpO2 (peripheral saturation) > 5% during the upright position and an improvement on recumbency (platypnea/ortodeoxya syndrome) can be suspect for righ-to-left shunt, e.g. intrapulmonary shunt or most frequently a patent foramen ovale.
Among COPD patients, several studies showed a higher prevalence of patent foramen ovale than in general population (70% versus 35%). Chest imaging and echocardiogram with bubble contrast should be the first clinical assessment to differentiate subjects with intracardiac shunt (such as in Patent foramen ovale) from those with extracardiac (or intrapulmonary) one.
Definitive treatment of right-to-left shunt involves percutaneous closure but literature provides conflicting data about indications and results, particularly regarding selection of COPD patients to be subjected to such intervention. Several key factors should be taken into account from a clinical and ethical point of view: first periprocedural complications, then echocardiographic assessment of right ventricular systolic and diastolic performance should be performed to rule out severe pulmonary hypertension and to avoid further post-procedure clinical deterioration; in addition, quality of life should be assessed.
In our experience, among 12 patients with patent foramen ovale 5 were affected by COPD GOLD III with refractory hypoxaemia. After evaluation of right ventricular performance, only 2 patients were eligible for patent foramen ovale closure with the Amplatzer device; long-term follow-up showed discontinuation of oxygen therapy and improvement in quality of life. Therefore, COPD patients with hypoxaemia refractory to high O2 supplementation must be thoroughly assessed taking into account a careful history and a targeted physical examination. The presence of patent foramen ovale should raise suspicion of a right-to-left shunt. If a patent foramen ovale is identified, evaluation of pulmonary function, right ventricular systolic reserve, and severity of pulmonary hypertension is mandatory for closure.
The development of a multidisciplinary team to conduct a multicenter study is necessary to understand if and when the right-to-left shunt in COPD can benefit from this novel therapy.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. Global Strategy for the diagnosis, management, and prevention of COPD (GOLD 2023), available on the GOLD website: www.goldcopd.org
3. Bagdonas E, Raudoniute J , Bruzauskaite I, Aldonyte R. Novel aspects of pathogene sis and regeneration mechanisms in COPD. Int J Chron Obstruct Pulmon Dis . 2015 Jun 2;10:995-1013. doi: 10.2147/COPD.S82518. PMID: 26082624 PMCID: PMC4459624
4. Kaur M, Chandel J, Malik J. et al. Particulate matter in COPD pathogenesis: an overview. Published online 2019 Oct 26. doi: 10.15326/jcopdf.6.5.2019.0149
5. Brashier BB , Kodgule R. Risk factors and pathophysiology of chronic obstructive pulmo-nary disease (COPD). J Assoc Physicians India. 2012 Feb; 60 Suppl:17-21. PMID: 23155808
6. Barbera` JA, Peinado V.I, Santos S. Pulmonary hypertension in chronic obstructive pulmonary disease. Eur Respir J 2003; 21: 892–905 DOI: 10.1183/09031936.03.00115402
7. Kovacs G, Agusti A, Barbera`JA, Celli B, Criner G, Humbert M, et al. Pulmonary Vascular Involvement in Chronic Obstructive Pulmonary Disease. Is There a Pulmonary Vascular Phenotype? American Journal of Respiratory and Critical Care Medicine Volume 198 Number 8 | October 15, 2018.
8. Cooper CB, Celli B. Venous admixture in COPD: pathophysiology and therapeutic ap-proaches COPD. 2008 Dec;5(6):376-81. DOI: 10.1080/15412550802522783 PMID: 19353352 PMCID: PMC2645850
9. Said SI, Banerjee CM. Venous admixture to the pulmonary circulation in human subjects breathing 100 per cent oxygen. J Clin Invest. 1963;42(4):507-515. https://doi.org/10.1172/JCI104739
10. Agrawal A, Palkar A, Talwar A. The multiple dimensions of Platypnea-Orthodeoxia syndrome: A review . Respir Med . 2017 Aug;129:31-38. doi: 10.1016/j.rmed.2017.05.016. Epub 2017 May 31.
11. Gossage JR, Kanj G. Pulmonary Arteriovenous Malformations. A State of the Art Review. Am J Respir Crit Care Med .Vol 158. pp 643–661, 1998.
12. Lovering AT, Riemer RK , Thébaud B. Intrapulmonary Arteriovenous Anastomoses. Physiological, Pathophysiological, or Both? Ann Am Thorac Soc Vol 10, No 5, pp 504–508, Oct 2013 DOI: 10.1513/Annals ATS.201308-265ED
13. Balchum OJ, Jung RC, Franklin Turner A, Jacobson G. Pulmonary Artery to Vein Shunts in Obstructive Pulmonary Disease. American Journal of Medicine Vol. 43, 178-185, August 1967.
14. Tobin CE , Zariquiey MO. Bronchopulmonary segments and blood supply of the human lung; a radiographic and anatomic study. Med Radiogr 26,38–45 (1950).
15. Miller WC, ]ohn G, Heard JG, Unger KM. Enlarged Pulmonary Arteriovenous Vessels in COPO. Another Possible Mechanism of Hypoxemia. CHEST / 86 / 5 / November. 1984 704-706.
16. Cameron Norris H, Mangum TS, Kern JP, Elliott JE et al. Intrapulmonary arteriovenous anastomoses in humans with chronic obstructive pulmonary disease: implications for cryptogenic stroke? Exp Physiol 101.8 (2016) 1128–1142.
17. Sharma S. Pulmonary Arterovenous Malformation (PAVM): Imaging and Diagnosis. Radiology Updated: Dec 07, 2020.
18. Hagen PT , Scholz DG, Edwars WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc, 59 (1984), 17-20.
19. Bernard S, Churchill TW, Namasivayam M, Bertrand PB. Agitated Saline Contrast Echo-cardiography in the Identification of Intra- and Extracardiac Shunts: Connecting the Dots. J Am Soc Echocardiogr . 2020 Oct 23; S0894-7317 (20) 30615-5. DOI: 10.1016/j.echo.2020.09.013 PMID: 34756394
20. Michael E, Layou ME, Aboulhosn JA, Tobis JM. Potential Role of Patent Foramen Ovale in Exacerbating Hypoxemia in Chronic Pulmonary Disease. Tex Heart Inst J. 2017 Jun; 44(3): 189–197.doi: 10.14503/THIJ-16-6027 PMCID: PMC5505397 PMID: 28761399
21. Bancal C. Patent foramen ovale and hypoxaemia with or without elevated right heart pressures. Rev. Mal. Respir. 28 (8) (2011) 967–977, https://doi.org/ 10.1016/j. rmr.2011.07.001. Oct.
22. Soliman A, Shanoudy H, Liu J. Increased prevalence of patent foramen ovale in patients with severe chronic obstructive pulmonary disease, J. Am. Soc. Echocardiogr. 12 (1999) 99–105, https://doi.org/10.1378/chest.113.1.91.
23. Hacievliyagil SS, Gunen H, Kosar FM, Sahin I, Kilic T. Prevalence and clinical signifi-cance of a patent foramen ovale in patients with chronic obstructive pulmonary disease, Respir. Med. 100 (5) (2006) 903–910,
https://doi.org/10.1016/j.rmed.2005.08.015
24. Kilic H, Gülsoy GK. Patent foramen ovale among patients with mild chronic obstructive pulmonary disease and unexplained hypoxia, Echocardiography 27 (6) (2010) 687–690, https://doi.org/10.1111/j.1540-8175.2009.01105.x. Jul.
25. Martolini D, Tanner R, Davey C, Patel MS, Elia D, Purcell H. Significance of patent fora-men ovale in patients with GOLD Stage II chronic obstructive pulmonary disease, J. COPD F. 12 (2014) 185–192,
https://doi.org/10.15326/jcopdf.1.2.2013.0003.
26. Shaikh ZF, Kelly JL, Shrikrishna D, de Villa M, Mullen MJ, Hopkinson NS. Patent fora-men ovale is not associated with hypoxemia in severe chronic obstructive pulmonary dis-ease and does not impair exercise performance . Am. J. Respir. Crit. Care Med. 189 5 (2014) 540–547, https://doi.org/10.14503/ THIJ-16-6027.
27.Terry PB, White RI, Barth KH, Kaufman S L, Mitchell SE. Pulmonary arteriovenous mal-formations: physiologic observations and results of therapeutic balloon embolization. N. Engl. J. Med. 308198311971200.
28. Chilvers ER, Whyte MK, Jackson JE, Allison DJ, Hughes JM. Effect of percutaneous transcatheter embolization on pulmonary function, right-to-left shunt and arterial oxygenation in patients with pulmonary arteriovenous malformations. Am. Rev. Respir. Dis.1421990420425
29. Pennington DW, Gold WM, Gordon RL, Steiger D, Ring EJ, Golden JA. Treatment of pul-monary arteriovenous malformations by therapeutic embolization: rest and exercise physi-ology in eight patients. Am. Rev. Respir. Dis.145199210471051.
30. Chiau-Suong L, Jong-Kai H, I-Tseng C. Pulmonary Arteriovenous Fistula with Pulmonary Hypertension - To Close or Not to Close? Acta Cardiol Sin. 2016 Jan; 32(1): 116–119. doi: 10.6515/ACS20150424F PMCID: PMC4804951 PMID: 27122941
31. El Tahlawi M, Jop B , Bonello B, Dragulescu A, Rouault F , Habib G , et al. Should we close hypoxaemic patent foramen ovale and interatrial shunts on a systematic basis? Arch. Cardiovasc. Dis., 102 (11) (2009 Nov), 755-759, 10.1016/j.acvd.2009.09.009 Epub 2009 Nov 14 Volume 104, Issue 6, December 1993: 1673-1675.
32. Nootens M, Laurence A, Berarducci D, Kaufmann E RN , Devries S, Rich S. The Prevalence and Significance of a Patent Foramen Ovale in Pulmonary Hypertension https://doi.org/10.1378/chest.104.6.1673 CHEST Volume 104, Issue 6, December 1993:1673-1675.
33. Guérin P, Lambert V, Godart F, Legendre A, Petit J, Bourlon F, De Geeter B, Petit A, Mon-rozier B, Rossignol AM, Jimenez M, Crochet D, Choussat A, Rey C, Losay J. Transcatheter closure of patent foramen ovale in patients with platypnea-orthodeoxia: results of a multi-centric French registry. Cardiovasc Intervent Radiol 2005;28:164-885.
34. Shah AH, Osten M, Leventhal A, Bach Y, Yoo D, Mansour D, Benson L, Wilson WM, Horlick E. Percutaneous Intervention to Treat Platypnea-Orthodeoxia Syndrome: The To-ronto Experience. JACC Cardiovasc Interv 2016;9:1928-38.
35. Zaidi A, Knight DS, Augustine DX, Harkness A, Oxborough D, Pearce K,et al. and the Education Committee of the British Society of Echocardiograph. Echocardiographic as-sessment of the right heart in adults: a practical guideline from the British Society of Echocardiography .Echo Res Pract. 2020 Mar; 7(1): G19–G41. doi: 10.1530/ERP-19-0051 PMCID: PMC7077526 PMID: 32105053
36. Frizzelli R, Lettieri C, Caiola S , Maulucci L, Pinzi C, Agostini F, Frizzelli A. Unex-plained hypoxemia in COPD with cardiac shunt. Respir Med Case Rep . 2022 May 5;37:101661. doi: 10.1016/j.rmcr.2022.101661. eCollection 2022. PMID: 35585906 PMCID: PMC9108509